AOK has received funding from the European Union’s 7th Framework programme for research and innovation the Marie Skłodowska-Curie Grant Agreement No. 609402-2020 researchers: Train to Move (T2M).MM received funding from the European Union’s Horizon 2020 research and innovation programme under the Skłodowska-Curie Grant Agreement No. 658483. NMP is supported by the European Research Council grant 2015 SILKENE No. 693670, EU FETPROACTIVE grant 732344 ‘NEUROFIBRES’, and by the Commission under the Graphene Flagship (WP14 ‘Polymer Nanocomposites’, No. 604391). FB is EU FETPROACTIVE grant 732344 ‘NEUROFIBRES’.
No takes yet. Share an insight, caveat, or question.
Krushynska et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: